ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNSE Sensei Biotherapeutics Inc

0.9917
0.00 (0.00%)
Pre Market
Last Updated: 04:00:01
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Sensei Biotherapeutics Inc SNSE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.9917 04:00:01
Open Price Low Price High Price Close Price Prev Close
0.9917
more quote information »

Recent News

Date Time Source Heading
3/05/202416:44EDGAR2Form 8-K - Current report
2/28/202407:31EDGAR2Form 8-K - Current report
2/16/202418:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202418:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:31EDGAR2Form 8-K - Current report
1/04/202408:14EDGAR2Form 8-K - Current report
11/07/202316:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202307:35EDGAR2Form 8-K - Current report
11/07/202307:30GLOBESensei Biotherapeutics Reports Third Quarter 2023 Financial..
11/06/202306:07EDGAR2Form 8-K - Current report
11/03/202316:11EDGAR2Form 8-K - Current report
11/03/202316:05GLOBESensei Biotherapeutics Reports Favorable Clinical Data for..
11/02/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202316:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/01/202307:30GLOBESensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as..
10/25/202309:05GLOBESensei Biotherapeutics to Present Initial Clinical Data from..
10/23/202307:30GLOBESensei Biotherapeutics Presents Trial-in-Progress Poster for..
10/20/202317:01EDGAR2Form 8-K - Current report
9/27/202307:30GLOBESensei Biotherapeutics Announces Initiation of Combination..
9/21/202307:30GLOBESensei Biotherapeutics Presents New Preclinical Data..
9/13/202308:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/13/202307:30GLOBESensei Biotherapeutics to Present New Preclinical Data..
9/11/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/11/202317:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/11/202317:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/11/202317:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/30/202307:30GLOBESensei Biotherapeutics to Participate in Upcoming Investor..
8/17/202317:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/03/202316:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202308:45EDGAR2Form 8-K - Current report
8/03/202307:30GLOBESensei Biotherapeutics Reports Second Quarter 2023 Financial..
8/02/202317:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/02/202307:30GLOBESensei Biotherapeutics to Participate in Canaccord Genuity’s..
7/12/202316:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/12/202316:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/12/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/12/202316:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/12/202316:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/10/202316:31EDGAR2Form 8-K - Current report
6/01/202307:30GLOBESensei Biotherapeutics Announces First Patient Dosed in..
5/09/202307:30GLOBESensei Biotherapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock